TSC2 and tuberous sclerosis: Patients with primary TSC disease and sporadic EAML due to various causes have mutations in the TSC1 and TSC2 genes, resulting in the inability of hamartin and tuberin to form complexes, leading to an increase in RHEB‐GTP that binds to mTOR1 to form activated mTORC1.